These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 20195007

  • 21. Incremental cost-effectiveness of a collaborative care intervention for panic disorder.
    Katon W, Russo J, Sherbourne C, Stein MB, Craske M, Fan MY, Roy-Byrne P.
    Psychol Med; 2006 Mar; 36(3):353-63. PubMed ID: 16403243
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D, Baingana F, Kim J.
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [Abstract] [Full Text] [Related]

  • 23. A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.
    Demyttenaere K, Hemels ME, Hudry J, Annemans L.
    Clin Ther; 2005 Jan; 27(1):111-24. PubMed ID: 15763612
    [Abstract] [Full Text] [Related]

  • 24. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
    Simon GE, Ludman EJ, Bauer MS, Unützer J, Operskalski B.
    Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
    [Abstract] [Full Text] [Related]

  • 25. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ, Botteman MF, Schaefer K, Sarocco P, Barry N, Pickard AS.
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [Abstract] [Full Text] [Related]

  • 26. Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial.
    Knapp M, Romeo R, Mogg A, Eranti S, Pluck G, Purvis R, Brown RG, Howard R, Philpot M, Rothwell J, Edwards D, McLoughlin DM.
    J Affect Disord; 2008 Aug; 109(3):273-85. PubMed ID: 18262655
    [Abstract] [Full Text] [Related]

  • 27. A supported self-help for recurrent depression in primary care; An economic evaluation alongside a multi-center randomised controlled trial.
    Biesheuvel-Leliefeld KEM, Bosmans JE, Dijkstra-Kersten SMA, Smit F, Bockting CLH, van Schaik DJF, van Marwijk HWJ, van der Horst HE.
    PLoS One; 2018 Aug; 13(12):e0208570. PubMed ID: 30566441
    [Abstract] [Full Text] [Related]

  • 28. A model of the economic impact of a bipolar disorder screening program in primary care.
    Menzin J, Sussman M, Tafesse E, Duczakowski C, Neumann P, Friedman M.
    J Clin Psychiatry; 2009 Sep; 70(9):1230-6. PubMed ID: 19689919
    [Abstract] [Full Text] [Related]

  • 29. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK, Drevs F.
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [Abstract] [Full Text] [Related]

  • 30. Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients.
    Datta SK, Oddone EZ, Olsen MK, Orr M, McCant F, Gentry P, Bosworth HB.
    Am Heart J; 2010 Aug; 160(2):257-63. PubMed ID: 20691830
    [Abstract] [Full Text] [Related]

  • 31. Mental health care system optimization from a health-economics perspective: where to sow and where to reap?
    Lokkerbol J, Weehuizen R, Mavranezouli I, Mihalopoulos C, Smit F.
    J Ment Health Policy Econ; 2014 Jun; 17(2):51-60. PubMed ID: 25153093
    [Abstract] [Full Text] [Related]

  • 32. Cost-effectiveness of alternative treatments for depression in low-income women.
    Beil H, Beeber LS, Schwartz TA, Lewis G.
    J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
    [Abstract] [Full Text] [Related]

  • 33. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
    Eveleigh R, Grutters J, Muskens E, Oude Voshaar R, van Weel C, Speckens A, Lucassen P.
    Fam Pract; 2014 Oct; 31(5):578-84. PubMed ID: 25121977
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.
    Simon GE, Katon WJ, VonKorff M, Unützer J, Lin EH, Walker EA, Bush T, Rutter C, Ludman E.
    Am J Psychiatry; 2001 Oct; 158(10):1638-44. PubMed ID: 11578996
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prevention of anxiety and depression in the age group of 75 years and over: a randomised controlled trial testing the feasibility and effectiveness of a generic stepped care programme among elderly community residents at high risk of developing anxiety and depression versus usual care [ISRCTN26474556].
    van 't Veer-Tazelaar N, van Marwijk H, van Oppen P, Nijpels G, van Hout H, Cuijpers P, Stalman W, Beekman A.
    BMC Public Health; 2006 Jul 18; 6():186. PubMed ID: 16848888
    [Abstract] [Full Text] [Related]

  • 39. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.
    Wiles NJ, Thomas L, Turner N, Garfield K, Kounali D, Campbell J, Kessler D, Kuyken W, Lewis G, Morrison J, Williams C, Peters TJ, Hollinghurst S.
    Lancet Psychiatry; 2016 Feb 18; 3(2):137-44. PubMed ID: 26777773
    [Abstract] [Full Text] [Related]

  • 40. Economic evaluation of an Internet-based weight management program.
    Rasu RS, Hunter CM, Peterson AL, Maruska HM, Foreyt JP.
    Am J Manag Care; 2010 Apr 01; 16(4):e98-104. PubMed ID: 20370312
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.